173 related articles for article (PubMed ID: 14507079)
1. Reporting adverse vaccine events.
O'Rourke K
J Am Vet Med Assoc; 2003 Sep; 223(6):753-4. PubMed ID: 14507079
[No Abstract] [Full Text] [Related]
2. Vaccine adverse event reporting: the importance of follow-up.
Varricchio F
Expert Rev Vaccines; 2005 Aug; 4(4):445-8. PubMed ID: 16117700
[No Abstract] [Full Text] [Related]
3. Invited commentary--prescription drug label adverse events: a call for prioritization: comment on "A quantitative analysis of adverse events and 'overwarning' in drug labeling".
Cheng C; Guglielmo BJ
Arch Intern Med; 2011 May; 171(10):946-7. PubMed ID: 21606102
[No Abstract] [Full Text] [Related]
4. Impact of new regulations for pediatric labeling by the Food and Drug Administration.
Buck ML
Pediatr Nurs; 2000; 26(1):95-6. PubMed ID: 12026326
[No Abstract] [Full Text] [Related]
5. A quantitative analysis of adverse events and "overwarning" in drug labeling.
Duke J; Friedlin J; Ryan P
Arch Intern Med; 2011 May; 171(10):944-6. PubMed ID: 21606101
[No Abstract] [Full Text] [Related]
6. Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: the importance of reporting suspected reactions.
Wysowski DK; Swartz L
Arch Intern Med; 2005 Jun; 165(12):1363-9. PubMed ID: 15983284
[TBL] [Abstract][Full Text] [Related]
7. Guillain-Barré syndrome after vaccination in United States: data from the Centers for Disease Control and Prevention/Food and Drug Administration Vaccine Adverse Event Reporting System (1990-2005).
Souayah N; Nasar A; Suri MF; Qureshi AI
J Clin Neuromuscul Dis; 2009 Sep; 11(1):1-6. PubMed ID: 19730016
[TBL] [Abstract][Full Text] [Related]
8. Red sky in the morning: modifying prescription drug labels as a result of postmarket surveillance.
Jacobson JD; Feigal D
Food Drug Law J; 2007; 62(3):529-46. PubMed ID: 17915395
[No Abstract] [Full Text] [Related]
9. Botanical medicines--the need for new regulations.
Marcus DM; Grollman AP
N Engl J Med; 2002 Dec; 347(25):2073-6. PubMed ID: 12490692
[No Abstract] [Full Text] [Related]
10. Lessons from cisapride.
CMAJ; 2001 May; 164(9):1269, 1271. PubMed ID: 11341130
[No Abstract] [Full Text] [Related]
11. Toll-free number for reporting adverse events on labeling for human drug products. Interim final rule.
Food and Drug Administration, HHS
Fed Regist; 2008 Jan; 73(2):402-4. PubMed ID: 18389912
[TBL] [Abstract][Full Text] [Related]
12. Comparing data mining methods on the VAERS database.
Banks D; Woo EJ; Burwen DR; Perucci P; Braun MM; Ball R
Pharmacoepidemiol Drug Saf; 2005 Sep; 14(9):601-9. PubMed ID: 15954077
[TBL] [Abstract][Full Text] [Related]
13. Cisapride and patient information leaflets.
Sukkari SR; Sasich LD
CMAJ; 2001 May; 164(9):1276-8; author reply 1278-9. PubMed ID: 11341134
[No Abstract] [Full Text] [Related]
14. Adverse events after anthrax vaccination reported to the Vaccine Adverse Event Reporting System (VAERS), 1990-2007.
Niu MT; Ball R; Woo EJ; Burwen DR; Knippen M; Braun MM;
Vaccine; 2009 Jan; 27(2):290-7. PubMed ID: 18992783
[TBL] [Abstract][Full Text] [Related]
15. Nationwide vaccine adverse events reporting system.
Nightingale SL
Am Fam Physician; 1991 Mar; 43(3):1053-4. PubMed ID: 2000717
[No Abstract] [Full Text] [Related]
16. Toll-free number for reporting adverse events on labeling for human drug products. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2008 Oct; 73(209):63886-97. PubMed ID: 19112682
[TBL] [Abstract][Full Text] [Related]
17. New vaccine reports from FDA to the Uppsala Monitoring Centre.
Hill R
Int J Risk Saf Med; 2011; 23(2):117-8. PubMed ID: 21673420
[No Abstract] [Full Text] [Related]
18. How can you promote vaccine safety?
Miller ER; Iskander J; Pickering S; Varricchio F
Nursing; 2007 Apr; 37(4):58-63; quiz 63-4. PubMed ID: 17413371
[No Abstract] [Full Text] [Related]
19. Safety of influenza A (H1N1) 2009 monovalent vaccines - United States, October 1-November 24, 2009.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2009 Dec; 58(48):1351-6. PubMed ID: 20010511
[TBL] [Abstract][Full Text] [Related]
20. "Black Box" warning labels and drug withdrawals.
Thomas JA
Toxicol Appl Pharmacol; 2002 Sep; 183(2):81. PubMed ID: 12387746
[No Abstract] [Full Text] [Related]
[Next] [New Search]
